XML 118 R90.htm IDEA: XBRL DOCUMENT v3.20.2
RELATED PARTY TRANSACTIONS (Narrative) (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Aug. 31, 2020
CAD ($)
Share
$ / shares
Aug. 31, 2019
CAD ($)
Share
shares
$ / shares
Disclosure of transactions between related parties [line items]    
Stock options granted 2,125,000 3,589,500
Weighted average exercise price of share options granted in share-based payment arrangement | $ / shares $ 3.21 $ 7.59
Number of warrants exercised | shares   7,739,205
Warrants exercised, weighted average exercise price | $ / shares   $ 4.00
RSUs [Member]    
Disclosure of transactions between related parties [line items]    
Number of other equity instruments granted in share-based payment arrangement 265,258 879,635
Performance share units ("PSUs") [Member]    
Disclosure of transactions between related parties [line items]    
Number of other equity instruments granted in share-based payment arrangement 142,187  
Key management personnel [Member]    
Disclosure of transactions between related parties [line items]    
Stock options granted 790,000 685,000
Weighted average exercise price of share options granted in share-based payment arrangement | $ / shares $ 2.48 $ 4.75
Aggregate fair value stock options granted to key management personnel | $ $ 1,794 $ 1,736
Key management personnel [Member] | RSUs [Member]    
Disclosure of transactions between related parties [line items]    
Number of other equity instruments granted in share-based payment arrangement 211,981 631,949
Aggregate fair value of RSUs granted to key management personnel | $ $ 902 $ 3,002
Key management personnel [Member] | Performance share units ("PSUs") [Member]    
Disclosure of transactions between related parties [line items]    
Number of other equity instruments granted in share-based payment arrangement 88,910
Aggregate fair value of PSUs granted to key management personnel | $ $ 191
Eviana Health Corporation ("Eviana") [Member]    
Disclosure of transactions between related parties [line items]    
Amount of interest income received on convertible debenture investment | $   374
Alpha-cannabis Pharma GmbH ("ACG") [Member]    
Disclosure of transactions between related parties [line items]    
Revenues on product sold to related party | $ $ 52